Tools for Predicting the Functional Impact of Nonsynonymous Genetic Variation.
As personal genome sequencing becomes a reality, understanding the effects of genetic variants on phenotype-particularly the impact of germline variants on disease risk and the impact of somatic variants on cancer development and treatment-continues to increase in importance. Because of their clear potential for affecting phenotype, nonsynonymous genetic variants (variants that cause a change in the amino acid sequence of a protein encoded by a gene) have long been the target of efforts to predict the effects of genetic variation. Whole-genome sequencing is identifying large numbers of nonsynonymous variants in each genome, intensifying the need for computational methods that accurately predict which of these are likely to impact disease phenotypes. This review focuses on nonsynonymous variant prediction with two aims in mind: (1) to review the prioritization methods that have been developed to date and the principles on which they are based and (2) to discuss the challenges to further improving these methods.
Division of Bioinformatics, Department of Preventive Medicine, University of Southern California, Los Angeles, California 90033.
Haiming
0000-0001-7058-349X
H
Tang
Division of Bioinformatics, Department of Preventive Medicine, University of Southern California, Los Angeles, California 90033 pdthomas@usc.edu.
Paul D
0000-0002-9074-3507
PD
Thomas
D015894:Genome, Human; D055106:Genome-Wide Association Study / Q000379:methods*; D023281:Genomics / Q000379:methods*; D006801:Humans; D011110:Polymorphism, Genetic
genetic variation; human disease; phenotypic effects; protein mutation